Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Sarah De Val's paper "Venous Identity Requires BMP Signalling Through ALK3" reveals a major player in establishing vein identity.

Sarah De Val has published a major new paper in Nature Communications on 28th January 2019.

Sarah's lab aims to understand how blood and lymphatic vessels are formed, with the aspiration to use this knowledge to modulate vessel growth in pathologies. In particular, the mechanisms by which vein identity is established and maintained are currently very poorly understood, but it is crucial to understand these in order to improve our strategies of controlling vessel growth in order to successfully treat certain diseases. 

This paper identifies a major and previously unsuspected role for Bone Morphogenetic Proteins in the acquisition and maintenance of vein identity, through a detailed analysis of early vascular patterning in mice and zebrafish. BMPs are a group of growth factors originally discovered by their ability to induce the formation of bone and cartilage.

This work places BMP signalling at the top of a regulatory cascade that activates venous identity. It represents a fundamental advance in both our knowledge of vascular development and our understanding of the role of the BMP pathway. It also provides a wealth of novel targets for therapeutic manipulations of vascular growth, for example, in heart disease and cancer. - Associate Professor Sarah De Val

The full paper can be viewed here.

Similar stories

New blood test from DPAG cardiac researchers could save lives of heart attack victims

Researchers from the Herring group have developed a blood test that measures stress hormone levels after heart attacks. The test – costing just £10 – could ensure patients receive timely life-saving treatment.

Mootaz Salman set to target new treatments for stroke

The Chief Scientist Office of the Government of Scotland has awarded a collaborative grant of £298,966 to Dr Mootaz Salman to seek new therapeutic avenues to treat stroke.

New BBSRC grant to further our insights into how the cortex controls sleep

Professor of Sleep Physiology Vladyslav Vyazovskiy and Professor of Developmental Neuroscience Zoltán Molnár have been awarded a Project Grant from the Biotechnology and Biological Sciences Research Council (BBSRC) for “Brain mechanisms of sleep: top-down or bottom-up?”

Raised intracellular chloride levels underlie the effects of tiredness in cortex

A new study, co-authored by Professor Vladyslav Vyazovskiy, published in Nature Neuroscience, has revealed that intracellular chloride levels within cortical pyramidal neurons reflect sleep–wake history.

Key cause of type 2 diabetes uncovered

Research led by Dr Elizabeth Haythorne and Professor Frances Ashcroft reveals high blood glucose reprograms the metabolism of pancreatic beta-cells in diabetes. They have discovered that glucose metabolites, rather than glucose itself, are key to the progression of type 2 diabetes. Glucose metabolites damage pancreatic beta-cell function, so they are unable to release enough of the hormone insulin. Reducing the rate at which glucose is metabolised, and these glucose metabolites build up, can prevent the effects of hyperglycaemia.